Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin.
- DOI
- 10.1067/mcp.2001.113959
- Published
- 2001 Mar
- Container
- Clinical pharmacology and therapeutics
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1067/mcp.2001.113959,
title = {Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin.},
author = {Furuta T and Shirai N and Takashima M and Xiao F and Hanai H and Sugimura H and Ohashi K and Ishizaki T and Kaneko E},
year = {2001},
journal = {Clinical pharmacology and therapeutics},
doi = {10.1067/mcp.2001.113959},
url = {https://doi.org/10.1067/mcp.2001.113959}
}RIS
TY - JOUR TI - Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin. AU - Furuta T AU - Shirai N AU - Takashima M AU - Xiao F AU - Hanai H AU - Sugimura H AU - Ohashi K AU - Ishizaki T AU - Kaneko E PY - 2001 JO - Clinical pharmacology and therapeutics DO - 10.1067/mcp.2001.113959 UR - https://doi.org/10.1067/mcp.2001.113959 ER -
APA
T, F., N, S., M, T., F, X., H, H., H, S., K, O., T, I., & E, K. (2001). Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin.. Clinical pharmacology and therapeutics. https://doi.org/10.1067/mcp.2001.113959
Source records
- pubmed · retrieved 2026-09-25T07:00:45.648Z